A variational approach to magnetoelastic buckling problems for systems of superconducting tori

A variational principle for the magnetoelastic stability problem of superconductors is constructed. Independently, a pair of integral equations is derived, from which the initial and the perturbed field can be computed. The integral equations are solved for in-plane buckling of a slender pair of concentric tori, and out-of-plane buckling of a slender pair of equal coaxial tori. By using the variational principle, it is shown that both cases can become unstable when the currents on the two tori are equally directed, and the pertinent buckling values are calculated. The thus obtained buckling values are compared with the results of an alternative, mathematically less rigorous, method. A good correspondence between the two methods is found (at least as long as the two tori are not too near).     

On the Direct Addition of Amine N–H to Ch≡C Triple Bonds with Late Transition Metal Catalysts

The kinetics of the transition metal-catalysed direct addition of amine NH bonds to carbon--carbon multiple bonds (hydroamination) has been explored by in situ spectroscopic techniques. From an open mass balance it was concluded that an intermediate species was formed during the cyclisation of 6-aminohex-1-yne. This species was identified as the enamine 2-methylene-piperidine, which is the primary hydroamination product.     

A variational principle for magneto-elastic buckling

A variational principle that can serve as the basis for a magneto-elastic stability (or buckling) problem is constructed. For the two cases of soft ferromagnetic media and superconductors, respectively, it is shown how the variational principle directly yields an explicit expression for the buckling value. The formulation starts from a specific choice for a magneto-elastic Lagrangian L (associated with the so-called Maxwell-Minkowski model for magneto-elastic interactions). For the evaluation of the principle the first and second variations of L are calculated both inside and outside the solid magneto-elastic body. Thus, a general buckling criterion, consisting of an expression for the critical field value, together with a set of constraints for the field variables occurring in the right-hand side of this expression, is constructed. Finally, more detailed formulations are given for, successively, soft ferromagnetic bodies and superconductors. Applications to specific structures, yielding explicit numerical values for the magneto-elastic buckling fields, will be given in a forthcoming paper.     

The case of Gary: In search of post-hoc quixotic flexibility.

Responds to M. F. Hoyt's (see record 1995-22250-001) commentary on T. F. Van Denburg and E. J. Van Denburg's (see record 1994-18427-001) response to Hoyt's (see record 1994-18395-001) commentary on Van Denburg and Van Denburg's (see record 1993-06526-001) article about a case of premature therapy termination. Issues related to limits and flexibility in treatment are addressed. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Congenital pulmonary lymphangiectasis with chylothorax: a heterogeneous lymphatic vessel abnormality

We describe the generation of a new antipeptide antibody that binds to the centromeric region of human mitotic chromosomes. This antibody was raised against a synthetic peptide corresponding to the 481-493 amino acid sequence of the human CENP-B autoantigen. Immunofluorescence analysis revealed that this anti-CENP-B serum showed an identical pattern to the human CREST anticentromere autoantibody in both mitotic cells and interphase nuclei. Immunoblotting showed that this antibody reacts with the recombinant human CENP-B autoantigen, indicating that it is directed to the 80-kDa centromere polypeptide. We have used this serum to determine, by indirect immunofluorescence, whether CENP-B is conserved in different mammalian species. Surprisingly, the human antipeptide antibody does not react with the centromeric proteins of cultured mouse, hamster, or Indian muntjac cells. Because the CENP-B gene has been cloned in human and mouse, our results suggest that the CENP-B epitope used as an immunogen in this study is not ubiquitous in mammalian cells, and that we have most probably established a monospecific antibody to the human centromere.     

The C-terminus of c-ABL is required for proliferation and viability signaling in a c-ABL/erythropoietin receptor fusion protein

Activated ABL oncogenes cause B-cell leukemias in mice and chronic myelogenous leukemia in humans. However, the mechanism of transformation is complex and not well understood. A method to rapidly and reversibly activate c-ABL was created by fusing the extra-cytoplasmic and transmembrane domain of the erythropoietin (EPO) receptor with c-ABL (EPO R/ABL). When this chimeric receptor was expressed in Ba/F3 cells, the addition of EPO resulted in a dose-dependent activation of c-ABL tyrosine kinase and was strongly antiapoptotic and weakly mitogenic. To evaluate the contributions of various ABL domains to biochemical signaling and biological effects, chimeric receptors were constructed in which the ABL SH3 domain was deleted (triangle upSH3), the SH2 domain was deleted (triangle upSH2), the C-terminal actin-binding domain was deleted (triangle upABD), or kinase activity was eliminated by a point mutation, K290M (KD). The mutant receptors were stably expressed in Ba/F3 cells and analyzed for signaling defects, proliferation, viability, and EPO-induced leukemia in nude mice. When compared with the ability of the full-length EPO R/ABL receptor to induce proliferation and support viability in vitro, the triangle upSH3 mutant was equivalent, the triangle upSH2 mutant was moderately impaired, and the triangle upABD and KD mutants were profoundly impaired. None of these cell lines caused leukemia in mice in the absence of pharmacological doses of EPO. However, in mice treated with EPO (10 U/d), death from leukemia occurred rapidly with wild-type and triangle upSH3. However, time to death was prolonged by at least twofold for triangle upSH2 and greater than threefold for triangle upABD. This inducible model of ABL transformation provides a method to link specific signaling defects with specific biological defects and has shown an important role for the C-terminal actin-binding domain in proliferation and transformation in the context of this receptor/oncogene.     

Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis

1. The mechanism of renal protection by angiotensin-converting enzyme inhibition is still the subject of debate. Inhibition of proteinuria might play a role. If so, a good antiproteinuric response to angiotensin-converting enzyme inhibition should predict subsequent protection against renal structural damage. This hypothesis has not been tested in models where treatment is started after the renal disease is well established, i.e. models that mimic the clinical situation. 2. We therefore investigated this hypothesis in 96 male Wistar rats with established adriamycin nephrosis. Reduction of proteinuria was achieved by lisinopril (0, 2, 5 and 10 mg day-1 kg-1) on two different sodium diets (0.3% and 0.05% NaCl). Therapy started 6 weeks after adriamycin (at stable proteinuria) and was continued for 6 weeks. 3. Lisinopril reduced blood pressure by 32 +/- 4% and proteinuria by an average of 72 +/- 7%, with stabilization after 2 weeks. Considerable interindividual differences in antiproteinuric response was found. Glomerulosclerosis score was reduced by 15 +/- 5%. All the effects of angiotensin-converting enzyme inhibitors were enhanced by sodium depletion, but sodium depletion in itself did not affect blood pressure (124 +/- 4 mmHg), proteinuria (664 +/- 68 mg/day) or glomerulosclerosis score (30 +/- 5%). Interestingly, the more proteinuria was reduced initially in an individual rat, the less sclerosis was found in the long term in that rat. 4. In conclusion, angiotensin-converting enzyme inhibition lowers proteinuria and prevents glomerulosclerosis in established adriamycin nephrosis. These effects are enhanced by sodium depletion. The individual short-term antiproteinuric effect predicts the protection against ultimate glomerular damage. This is consistent with the hypothesis that reduction of proteinuria is a mechanism by which angiotensin-converting enzyme inhibitors exert renoprotection.     

Development of Bi(Pb)-2223/Ag pancake-shaped and solenoidal coils

High temperature superconducting (HTSC) multifilamentary (MT) Bi(Pb)-2223/Ag tapes with reproducible critical current density of between 15000 and 20000 A/cm² at 77 K in self field have been achieved using the standard flat-rolling method as the intermediate deformation between sintering periods. Long lengths of Bi(Pb)-2223/Ag MT tapes up to 43 m prepared by the conventional method of powder-in-tube (PIT) have been successfully produced on a laboratory scale. Several coils have been fabricated from sections of the long length tape, using the co-wound wind-and-react (W&R) procedure for the pancake-shaped and the singly-wound W&R as well as R&W procedure for the solenoidal coils. A novel W&R solenoidal coil (reaching ~973 ampere-turns) wound on an alumina ceramic tube generates a DC field of ~19 mT at 77 K and has been fabricated together with five pancake-shaped coils, each generating an average of ~5 mT at 77 K. These are destined for magnet construction with a possible combined calculated field of ~0.04 T at 77 K (with liquid nitrogen as a coolant)